Wall St. Cashes Out, Peace Deal Crashes Out, Semiconductors Smashed Up
Let’s check the fighting with Iran, why Wall St. is cashing out, how far the semis fell, and why inflation numbers are more nuanced than they appear.
Ready for the SpaceX IPO?: 8 Key Items Shaping the Stock Market Thursday
Trump and Iran, May PPI, Oracle’s spending, potential OpenAI price cuts, and other headlines moving stocks this morning.
The Strong Open and Weak Close Pattern Is a Warning
Lower oil is boosting the market as investors await the SpaceX IPO.
Tech Investors Aren’t Used to This Kind of Selling
As the market drops, investors are becoming anxious. Should we be looking for a bottom?
Just Barely Head and Shoulders Above the 50-Day Moving Average
Let’s chat about market sentiment, that pesky head and shoulders top, and moving averages.
Bounce Fails and Now Major Market Catalysts Are Piling Up
After another disappointing day, the market faces three key issues.
Looming Mandate Could Be Big Deal for New Bullpen Name
If history holds, we are likely to see mandate pre-buying for the latest addition to our bullpen.
Chart of the Day: IPOs Are Exciting if You Already Own a Piece
SuRo is an investor in one of the big three upcoming IPOs, but it’s not SpaceX.
These Biopharma Names Don’t Have the Flash of SpaceX, but They’re Reliable
Here are four biotech plays that should stand up if the market starts to break down.
Spotlight Shines on a SuRo Capital Position…And It’s Not the One You Think
It’s not OpenAI, nor is it affiliated with Nvidia.